Serum Erythropoietin Level in Type II Diabetic Nephropathy BC05-BC08
Dr. Mahmoud Hussein Hadwan,
Al-Imam Ali St. hilla, Hilla, Babylon, Iraq.
Introduction: Diabetes is a disease characterised by poor glycaemic control and development of various complications with age. Diabetic complications include development of nephropathy as well as other complications.
Aim: The study was aimed to elucidate the consequences of diabetic nephropathy on erythropoietin levels and microalbuminuria.
Materials and Methods: A total of 66 subjects with Type II Diabetes Mellitus (T2DM) with and without microalbuminuria and 22 healthy subjects were enrolled in the present study. The following case-control study was completed in Al-Najaf Centre for Diabetes and Endocrinology, Al-Najaf City, Iraq from March 2016 to May 2016. Serum erythropoietin levels and microalbuminuria concentrations were documented in addition to demographic and biochemical data.
Results: Serum erythropoietin concentrations were decreased significantly in patients with T2DM compared to that of healthy control subjects. Microalbuminuria concentrations were increased significantly in patients with T2DM compared to that of healthy control subjects.
Conclusion: Microalbuminuria and erythropoietin levels can be used to assess the occurance of complications in patients with diabetic nephropathy.